APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Device Software Validation

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Medical Device Software Validation Market Analysis and Forecast 2026-2032

5 June 2026191 pages

Choose your research edition.

Industry ResearchMedical Device Software Validation Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Device Software Validation Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Medical Device Software Validation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Device Software Validation Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Device Software Validation Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Medical Device Software Validation market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Medical Device Software Validation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Medical Device Software Validation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Medical Device Software Validation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Medical Device Software Validation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Medical Device Software Validation include QbD Group, Intertek, SGS, QuEST, TÜV SÜD AG, NAMSA, Element, Eurofins Scientific and Charles River, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Medical Device Software Validation, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Medical Device Software Validation, also provides the revenue of main regions and countries. Of the upcoming market potential for Medical Device Software Validation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Medical Device Software Validation revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Medical Device Software Validation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Medical Device Software Validation revenue, projected growth trends, production technology, application and end-user industry.

Medical Device Software Validation Segment by Company

QbD Group

Intertek

SGS

QuEST

TÜV SÜD AG

NAMSA

Element

Eurofins Scientific

Charles River

Sterling Medical Devices

Pacific Biolabs

Toxikon

Steris Laboratories

Europlaz Technologies

Tata Elxsi

Onyx Healthcare

Medical Device Software Validation Segment by Type

Unit Testing

Integration Testing

System Testing

Others

Medical Device Software Validation Segment by Application

Medical Device Manufacturing

Pharmaceutical

Biotechnology

Research and Development

Medical Device Software Validation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Device Software Validation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Device Software Validation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Device Software Validation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Medical Device Software Validation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Medical Device Software Validation company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Device Software Validation revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Medical Device Software Validation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Unit Testing Major Player Table 3. Integration Testing Major Player Table 4. System Testing Major Player Table 5. Others Major Player Table 6. Global Medical Device Software Validation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Medical Device Manufacturing Major Player Table 8. Pharmaceutical Major Player Table 9. Biotechnology Major Player Table 10. Research and Development Major Player Table 11. Medical Device Software Validation Industry Trends Table 12. Medical Device Software Validation Industry Drivers Table 13. Medical Device Software Validation Industry Opportunities and Challenges Table 14. Medical Device Software Validation Industry Restraints Table 15. Global Medical Device Software Validation Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Medical Device Software Validation Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Medical Device Software Validation Market Share by Region (2021-2026) Table 18. Global Medical Device Software Validation Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Medical Device Software Validation Market Share by Region (2027-2032) Table 20. Global Medical Device Software Validation Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Medical Device Software Validation Revenue Market Share by Players (2021-2026) Table 22. Global Medical Device Software Validation Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Medical Device Software Validation Key Players Headquarters & Area Served Table 24. Global Medical Device Software Validation Players, Product Type & Application Table 25. Global Medical Device Software Validation Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Medical Device Software Validation by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Medical Device Software Validation Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Medical Device Software Validation Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Medical Device Software Validation Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Medical Device Software Validation Revenue Market Share by Type (2021-2026) Table 32. Global Medical Device Software Validation Revenue Market Share by Type (2027-2032) Table 33. Global Medical Device Software Validation Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Medical Device Software Validation Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Medical Device Software Validation Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Medical Device Software Validation Revenue Market Share by Application (2021-2026) Table 37. Global Medical Device Software Validation Revenue Market Share by Application (2027-2032) Table 38. QbD Group Company Information Table 39. QbD Group Business Overview Table 40. QbD Group Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. QbD Group Medical Device Software Validation Product Portfolio Table 42. QbD Group Recent Development Table 43. Intertek Company Information Table 44. Intertek Business Overview Table 45. Intertek Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Intertek Medical Device Software Validation Product Portfolio Table 47. Intertek Recent Development Table 48. SGS Company Information Table 49. SGS Business Overview Table 50. SGS Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. SGS Medical Device Software Validation Product Portfolio Table 52. SGS Recent Development Table 53. QuEST Company Information Table 54. QuEST Business Overview Table 55. QuEST Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. QuEST Medical Device Software Validation Product Portfolio Table 57. QuEST Recent Development Table 58. TÜV SÜD AG Company Information Table 59. TÜV SÜD AG Business Overview Table 60. TÜV SÜD AG Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. TÜV SÜD AG Medical Device Software Validation Product Portfolio Table 62. TÜV SÜD AG Recent Development Table 63. NAMSA Company Information Table 64. NAMSA Business Overview Table 65. NAMSA Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. NAMSA Medical Device Software Validation Product Portfolio Table 67. NAMSA Recent Development Table 68. Element Company Information Table 69. Element Business Overview Table 70. Element Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Element Medical Device Software Validation Product Portfolio Table 72. Element Recent Development Table 73. Eurofins Scientific Company Information Table 74. Eurofins Scientific Business Overview Table 75. Eurofins Scientific Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Eurofins Scientific Medical Device Software Validation Product Portfolio Table 77. Eurofins Scientific Recent Development Table 78. Charles River Company Information Table 79. Charles River Business Overview Table 80. Charles River Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Charles River Medical Device Software Validation Product Portfolio Table 82. Charles River Recent Development Table 83. Sterling Medical Devices Company Information Table 84. Sterling Medical Devices Business Overview Table 85. Sterling Medical Devices Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Sterling Medical Devices Medical Device Software Validation Product Portfolio Table 87. Sterling Medical Devices Recent Development Table 88. Pacific Biolabs Company Information Table 89. Pacific Biolabs Business Overview Table 90. Pacific Biolabs Medical Device Software Validation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Pacific Biolabs Medical Device Software Validation Product Portfolio Table 92. Pacific Biolabs Recent Development Table 93. Toxikon Company Information Table 94. Toxikon Business Overview Table 95. Toxikon Medical Device Software Validation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Toxikon Medical Device Software Validation Product Portfolio Table 97. Toxikon Recent Development Table 98. Steris Laboratories Company Information Table 99. Steris Laboratories Business Overview Table 100. Steris Laboratories Medical Device Software Validation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Steris Laboratories Medical Device Software Validation Product Portfolio Table 102. Steris Laboratories Recent Development Table 103. Europlaz Technologies Company Information Table 104. Europlaz Technologies Business Overview Table 105. Europlaz Technologies Medical Device Software Validation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Europlaz Technologies Medical Device Software Validation Product Portfolio Table 107. Europlaz Technologies Recent Development Table 108. Tata Elxsi Company Information Table 109. Tata Elxsi Business Overview Table 110. Tata Elxsi Medical Device Software Validation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Tata Elxsi Medical Device Software Validation Product Portfolio Table 112. Tata Elxsi Recent Development Table 113. Onyx Healthcare Company Information Table 114. Onyx Healthcare Business Overview Table 115. Onyx Healthcare Medical Device Software Validation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Onyx Healthcare Medical Device Software Validation Product Portfolio Table 117. Onyx Healthcare Recent Development Table 118. North America Medical Device Software Validation Revenue by Type (2021-2026) & (US$ Million) Table 119. North America Medical Device Software Validation Revenue by Type (2027-2032) & (US$ Million) Table 120. North America Medical Device Software Validation Revenue by Application (2021-2026) & (US$ Million) Table 121. North America Medical Device Software Validation Revenue by Application (2027-2032) & (US$ Million) Table 122. North America Medical Device Software Validation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. North America Medical Device Software Validation Revenue by Country (2021-2026) & (US$ Million) Table 124. North America Medical Device Software Validation Revenue by Country (US$ Million) & (2027-2032) Table 125. Europe Medical Device Software Validation Revenue by Type (2021-2026) & (US$ Million) Table 126. Europe Medical Device Software Validation Revenue by Type (2027-2032) & (US$ Million) Table 127. Europe Medical Device Software Validation Revenue by Application (2021-2026) & (US$ Million) Table 128. Europe Medical Device Software Validation Revenue by Application (2027-2032) & (US$ Million) Table 129. Europe Medical Device Software Validation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Europe Medical Device Software Validation Revenue by Country (2021-2026) & (US$ Million) Table 131. Europe Medical Device Software Validation Revenue by Country (US$ Million) & (2027-2032) Table 132. China Medical Device Software Validation Revenue by Type (2021-2026) & (US$ Million) Table 133. China Medical Device Software Validation Revenue by Type (2027-2032) & (US$ Million) Table 134. China Medical Device Software Validation Revenue by Application (2021-2026) & (US$ Million) Table 135. China Medical Device Software Validation Revenue by Application (2027-2032) & (US$ Million) Table 136. Asia Medical Device Software Validation Revenue by Type (2021-2026) & (US$ Million) Table 137. Asia Medical Device Software Validation Revenue by Type (2027-2032) & (US$ Million) Table 138. Asia Medical Device Software Validation Revenue by Application (2021-2026) & (US$ Million) Table 139. Asia Medical Device Software Validation Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia Medical Device Software Validation Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Asia Medical Device Software Validation Revenue by Region (US$ Million) & (2021-2026) Table 142. Asia Medical Device Software Validation Revenue by Region (US$ Million) & (2027-2032) Table 143. SAMEA Medical Device Software Validation Revenue by Type (2021-2026) & (US$ Million) Table 144. SAMEA Medical Device Software Validation Revenue by Type (2027-2032) & (US$ Million) Table 145. SAMEA Medical Device Software Validation Revenue by Application (2021-2026) & (US$ Million) Table 146. SAMEA Medical Device Software Validation Revenue by Application (2027-2032) & (US$ Million) Table 147. SAMEA Medical Device Software Validation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. SAMEA Medical Device Software Validation Revenue by Country (2021-2026) & (US$ Million) Table 149. SAMEA Medical Device Software Validation Revenue by Country (US$ Million) & (2027-2032) Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Medical Device Software Validation Image Figure 2. Global Medical Device Software Validation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Device Software Validation Market Size Share 2021 VS 2025 VS 2032 Figure 4. Unit Testing Image Figure 5. Integration Testing Image Figure 6. System Testing Image Figure 7. Others Image Figure 8. Global Medical Device Software Validation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Medical Device Software Validation Market Size Share 2021 VS 2025 VS 2032 Figure 10. Medical Device Manufacturing Image Figure 11. Pharmaceutical Image Figure 12. Biotechnology Image Figure 13. Research and Development Image Figure 14. Global Medical Device Software Validation Market Size (US$ Million) & (2021-2032) Figure 15. Global Medical Device Software Validation Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Medical Device Software Validation Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Medical Device Software Validation Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Medical Device Software Validation Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Medical Device Software Validation Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Medical Device Software Validation Revenue Market Share by Type (2021-2032) Figure 22. Global Medical Device Software Validation Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Medical Device Software Validation Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Medical Device Software Validation Revenue Market Share by Application (2021-2032) Figure 25. North America Medical Device Software Validation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Medical Device Software Validation Revenue Share by Type (2021-2032) Figure 27. North America Medical Device Software Validation Revenue Share by Application (2021-2032) Figure 28. North America Medical Device Software Validation Revenue Share by Country (2021-2032) Figure 29. United States Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Medical Device Software Validation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Medical Device Software Validation Revenue Share by Type (2021-2032) Figure 34. Europe Medical Device Software Validation Revenue Share by Application (2021-2032) Figure 35. Europe Medical Device Software Validation Revenue Share by Country (2021-2032) Figure 36. Germany Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Medical Device Software Validation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Medical Device Software Validation Revenue Share by Type (2021-2032) Figure 46. China Medical Device Software Validation Revenue Share by Application (2021-2032) Figure 47. Asia Medical Device Software Validation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Medical Device Software Validation Revenue Share by Type (2021-2032) Figure 49. Asia Medical Device Software Validation Revenue Share by Application (2021-2032) Figure 50. Asia Medical Device Software Validation Revenue Share by Region (2021-2032) Figure 51. Japan Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Medical Device Software Validation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Medical Device Software Validation Revenue Share by Type (2021-2032) Figure 59. SAMEA Medical Device Software Validation Revenue Share by Application (2021-2032) Figure 60. SAMEA Medical Device Software Validation Revenue Share by Country (2021-2032) Figure 61. Brazil Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Medical Device Software Validation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Unit Testing
  • Integration Testing
  • System Testing
  • Others
Applications
  • Medical Device Manufacturing
  • Pharmaceutical
  • Biotechnology
  • Research and Development
Companies covered
  • QbD Group
  • Intertek
  • SGS
  • QuEST
  • TÜV SÜD AG
  • NAMSA
  • Element
  • Eurofins Scientific
  • Charles River
  • Sterling Medical Devices
  • Pacific Biolabs
  • Toxikon
  • Steris Laboratories
  • Europlaz Technologies
  • Tata Elxsi
  • Onyx Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Medical Device Software Validation Market by Type
  3. 1.2.1 Global Medical Device Software Validation Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Unit Testing
  5. 1.2.3 Integration Testing
  6. 1.2.4 System Testing
  7. 1.2.5 Others
  8. 1.3 Medical Device Software Validation Market by Application
  9. 1.3.1 Global Medical Device Software Validation Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Medical Device Manufacturing
  11. 1.3.3 Pharmaceutical
  12. 1.3.4 Biotechnology
  13. 1.3.5 Research and Development
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Medical Device Software Validation Market Dynamics
  1. 2.1 Medical Device Software Validation Industry Trends
  2. 2.2 Medical Device Software Validation Industry Drivers
  3. 2.3 Medical Device Software Validation Industry Opportunities and Challenges
  4. 2.4 Medical Device Software Validation Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Medical Device Software Validation Market Perspective (2021-2032)
  2. 3.2 Global Medical Device Software Validation Growth Trends by Region
  3. 3.2.1 Global Medical Device Software Validation Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Medical Device Software Validation Market Size by Region (2021-2026)
  5. 3.2.3 Global Medical Device Software Validation Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Medical Device Software Validation Revenue by Players
  2. 4.1.1 Global Medical Device Software Validation Revenue by Players (2021-2026)
  3. 4.1.2 Global Medical Device Software Validation Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Medical Device Software Validation Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Medical Device Software Validation Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Medical Device Software Validation Key Players Headquarters & Area Served
  7. 4.4 Global Medical Device Software Validation Players, Product Type & Application
  8. 4.5 Global Medical Device Software Validation Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Medical Device Software Validation Market CR5 and HHI
  11. 4.6.3 2025 Medical Device Software Validation Tier 1, Tier 2, and Tier 3
5 Medical Device Software Validation Market Size by Type
  1. 5.1 Global Medical Device Software Validation Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Medical Device Software Validation Revenue by Type (2021-2032)
  3. 5.3 Global Medical Device Software Validation Revenue Market Share by Type (2021-2032)
6 Medical Device Software Validation Market Size by Application
  1. 6.1 Global Medical Device Software Validation Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Medical Device Software Validation Revenue by Application (2021-2032)
  3. 6.3 Global Medical Device Software Validation Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 QbD Group
  2. 7.1.1 QbD Group Company Information
  3. 7.1.2 QbD Group Business Overview
  4. 7.1.3 QbD Group Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  5. 7.1.4 QbD Group Medical Device Software Validation Product Portfolio
  6. 7.1.5 QbD Group Recent Developments
  7. 7.2 Intertek
  8. 7.2.1 Intertek Company Information
  9. 7.2.2 Intertek Business Overview
  10. 7.2.3 Intertek Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Intertek Medical Device Software Validation Product Portfolio
  12. 7.2.5 Intertek Recent Developments
  13. 7.3 SGS
  14. 7.3.1 SGS Company Information
  15. 7.3.2 SGS Business Overview
  16. 7.3.3 SGS Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  17. 7.3.4 SGS Medical Device Software Validation Product Portfolio
  18. 7.3.5 SGS Recent Developments
  19. 7.4 QuEST
  20. 7.4.1 QuEST Company Information
  21. 7.4.2 QuEST Business Overview
  22. 7.4.3 QuEST Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  23. 7.4.4 QuEST Medical Device Software Validation Product Portfolio
  24. 7.4.5 QuEST Recent Developments
  25. 7.5 TÜV SÜD AG
  26. 7.5.1 TÜV SÜD AG Company Information
  27. 7.5.2 TÜV SÜD AG Business Overview
  28. 7.5.3 TÜV SÜD AG Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  29. 7.5.4 TÜV SÜD AG Medical Device Software Validation Product Portfolio
  30. 7.5.5 TÜV SÜD AG Recent Developments
  31. 7.6 NAMSA
  32. 7.6.1 NAMSA Company Information
  33. 7.6.2 NAMSA Business Overview
  34. 7.6.3 NAMSA Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  35. 7.6.4 NAMSA Medical Device Software Validation Product Portfolio
  36. 7.6.5 NAMSA Recent Developments
  37. 7.7 Element
  38. 7.7.1 Element Company Information
  39. 7.7.2 Element Business Overview
  40. 7.7.3 Element Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Element Medical Device Software Validation Product Portfolio
  42. 7.7.5 Element Recent Developments
  43. 7.8 Eurofins Scientific
  44. 7.8.1 Eurofins Scientific Company Information
  45. 7.8.2 Eurofins Scientific Business Overview
  46. 7.8.3 Eurofins Scientific Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Eurofins Scientific Medical Device Software Validation Product Portfolio
  48. 7.8.5 Eurofins Scientific Recent Developments
  49. 7.9 Charles River
  50. 7.9.1 Charles River Company Information
  51. 7.9.2 Charles River Business Overview
  52. 7.9.3 Charles River Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Charles River Medical Device Software Validation Product Portfolio
  54. 7.9.5 Charles River Recent Developments
  55. 7.10 Sterling Medical Devices
  56. 7.10.1 Sterling Medical Devices Company Information
  57. 7.10.2 Sterling Medical Devices Business Overview
  58. 7.10.3 Sterling Medical Devices Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Sterling Medical Devices Medical Device Software Validation Product Portfolio
  60. 7.10.5 Sterling Medical Devices Recent Developments
  61. 7.11 Pacific Biolabs
  62. 7.11.1 Pacific Biolabs Company Information
  63. 7.11.2 Pacific Biolabs Business Overview
  64. 7.11.3 Pacific Biolabs Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Pacific Biolabs Medical Device Software Validation Product Portfolio
  66. 7.11.5 Pacific Biolabs Recent Developments
  67. 7.12 Toxikon
  68. 7.12.1 Toxikon Company Information
  69. 7.12.2 Toxikon Business Overview
  70. 7.12.3 Toxikon Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Toxikon Medical Device Software Validation Product Portfolio
  72. 7.12.5 Toxikon Recent Developments
  73. 7.13 Steris Laboratories
  74. 7.13.1 Steris Laboratories Company Information
  75. 7.13.2 Steris Laboratories Business Overview
  76. 7.13.3 Steris Laboratories Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Steris Laboratories Medical Device Software Validation Product Portfolio
  78. 7.13.5 Steris Laboratories Recent Developments
  79. 7.14 Europlaz Technologies
  80. 7.14.1 Europlaz Technologies Company Information
  81. 7.14.2 Europlaz Technologies Business Overview
  82. 7.14.3 Europlaz Technologies Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Europlaz Technologies Medical Device Software Validation Product Portfolio
  84. 7.14.5 Europlaz Technologies Recent Developments
  85. 7.15 Tata Elxsi
  86. 7.15.1 Tata Elxsi Company Information
  87. 7.15.2 Tata Elxsi Business Overview
  88. 7.15.3 Tata Elxsi Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Tata Elxsi Medical Device Software Validation Product Portfolio
  90. 7.15.5 Tata Elxsi Recent Developments
  91. 7.16 Onyx Healthcare
  92. 7.16.1 Onyx Healthcare Company Information
  93. 7.16.2 Onyx Healthcare Business Overview
  94. 7.16.3 Onyx Healthcare Medical Device Software Validation Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Onyx Healthcare Medical Device Software Validation Product Portfolio
  96. 7.16.5 Onyx Healthcare Recent Developments
8 North America
  1. 8.1 North America Medical Device Software Validation Revenue (2021-2032)
  2. 8.2 North America Medical Device Software Validation Revenue by Type (2021-2032)
  3. 8.2.1 North America Medical Device Software Validation Revenue by Type (2021-2026)
  4. 8.2.2 North America Medical Device Software Validation Revenue by Type (2027-2032)
  5. 8.3 North America Medical Device Software Validation Revenue Share by Type (2021-2032)
  6. 8.4 North America Medical Device Software Validation Revenue by Application (2021-2032)
  7. 8.4.1 North America Medical Device Software Validation Revenue by Application (2021-2026)
  8. 8.4.2 North America Medical Device Software Validation Revenue by Application (2027-2032)
  9. 8.5 North America Medical Device Software Validation Revenue Share by Application (2021-2032)
  10. 8.6 North America Medical Device Software Validation Revenue by Country
  11. 8.6.1 North America Medical Device Software Validation Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Medical Device Software Validation Revenue by Country (2021-2026)
  13. 8.6.3 North America Medical Device Software Validation Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Medical Device Software Validation Revenue (2021-2032)
  2. 9.2 Europe Medical Device Software Validation Revenue by Type (2021-2032)
  3. 9.2.1 Europe Medical Device Software Validation Revenue by Type (2021-2026)
  4. 9.2.2 Europe Medical Device Software Validation Revenue by Type (2027-2032)
  5. 9.3 Europe Medical Device Software Validation Revenue Share by Type (2021-2032)
  6. 9.4 Europe Medical Device Software Validation Revenue by Application (2021-2032)
  7. 9.4.1 Europe Medical Device Software Validation Revenue by Application (2021-2026)
  8. 9.4.2 Europe Medical Device Software Validation Revenue by Application (2027-2032)
  9. 9.5 Europe Medical Device Software Validation Revenue Share by Application (2021-2032)
  10. 9.6 Europe Medical Device Software Validation Revenue by Country
  11. 9.6.1 Europe Medical Device Software Validation Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Medical Device Software Validation Revenue by Country (2021-2026)
  13. 9.6.3 Europe Medical Device Software Validation Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Medical Device Software Validation Revenue (2021-2032)
  2. 10.2 China Medical Device Software Validation Revenue by Type (2021-2032)
  3. 10.2.1 China Medical Device Software Validation Revenue by Type (2021-2026)
  4. 10.2.2 China Medical Device Software Validation Revenue by Type (2027-2032)
  5. 10.3 China Medical Device Software Validation Revenue Share by Type (2021-2032)
  6. 10.4 China Medical Device Software Validation Revenue by Application (2021-2032)
  7. 10.4.1 China Medical Device Software Validation Revenue by Application (2021-2026)
  8. 10.4.2 China Medical Device Software Validation Revenue by Application (2027-2032)
  9. 10.5 China Medical Device Software Validation Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Medical Device Software Validation Revenue (2021-2032)
  2. 11.2 Asia Medical Device Software Validation Revenue by Type (2021-2032)
  3. 11.2.1 Asia Medical Device Software Validation Revenue by Type (2021-2026)
  4. 11.2.2 Asia Medical Device Software Validation Revenue by Type (2027-2032)
  5. 11.3 Asia Medical Device Software Validation Revenue Share by Type (2021-2032)
  6. 11.4 Asia Medical Device Software Validation Revenue by Application (2021-2032)
  7. 11.4.1 Asia Medical Device Software Validation Revenue by Application (2021-2026)
  8. 11.4.2 Asia Medical Device Software Validation Revenue by Application (2027-2032)
  9. 11.5 Asia Medical Device Software Validation Revenue Share by Application (2021-2032)
  10. 11.6 Asia Medical Device Software Validation Revenue by Country
  11. 11.6.1 Asia Medical Device Software Validation Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Medical Device Software Validation Revenue by Country (2021-2026)
  13. 11.6.3 Asia Medical Device Software Validation Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Medical Device Software Validation Revenue (2021-2032)
  2. 12.2 SAMEA Medical Device Software Validation Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Medical Device Software Validation Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Medical Device Software Validation Revenue by Type (2027-2032)
  5. 12.3 SAMEA Medical Device Software Validation Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Medical Device Software Validation Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Medical Device Software Validation Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Medical Device Software Validation Revenue by Application (2027-2032)
  9. 12.5 SAMEA Medical Device Software Validation Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Medical Device Software Validation Revenue by Country
  11. 12.6.1 SAMEA Medical Device Software Validation Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Medical Device Software Validation Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Medical Device Software Validation Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst